Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors

Japanese Journal of Cancer Research

Volumn 89, Issue 8, 1998, Pages 797-805

  Arisawa, Kokichi ^a,b,c   Soda, Midori ^a   Akahoshi, Masazumi ^a   Matsuo, Tatsuki ^b   Nakashima, Eiji ^a   Tomonaga, Masao ^b   Saito, Hiroshi ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cohort study; HTLV I antibody; Liver neoplasms; Lymphoma; Mortality

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER MORTALITY; CANCER RISK; CHRONIC LIVER DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAPAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0031664762     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00631.x     Document Type: Article

References (36)

1. Poiesz, B. J., Ruscetti, F. W., Gazder, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous lymphoma. Proc. Natl. Acad. Sci. USA, 77, 7415-7419 (1980).
2. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K., Shirakawa, S. and Miyoshi, I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA, 78, 6476-6480 (1981).
3. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A. and de Thé, G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet, ii, 407-410 (1985).
4. Osame, M., Usuku, K., Izumo, S., Ijiri, N., Amitani, H., Igata, A., Matsumoto, M. and Tara, M. HTLV-I-associated myelopathy, a new clinical entity. Lancet, i, 1031-1032 (1986).
5. Nishioka, K., Maruyama, I., Sato, K., Kitajima, I., Nakajima, Y. and Osame, M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet, i, 441 (1989).
6. Vernant, J.-C., Buisson, G., Magdeleine, J., Thore, J. D., Jouannelle, A., Neisson-Vernant, C. and Monplaisir, N. T-Lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren's syndrome. Lancet, i, 177 (1988).
7. Terada, K., Katamine, S., Eguchi, K., Moriuchi, R., Kita, M., Shimada, H., Yamashita, I., Iwata, K., Tsuji, Y., Nagataki, S. and Miyamoto, T. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet, 344, 1116-1119 (1994).
8. Yamaguchi, K. Human T-lymphotropic virus type I in Japan. Lancet, 343, 213-216 (1994).
9. Yamashita, I., Katamine, S., Moriuchi, R., Nakamura, Y., Miyamoto, T., Eguchi, K. and Nagataki, S. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood, 84, 1573-1578 (1994).
10. Welles, S. L., Tachibana, N., Okayama, A., Shioiri, S., Ishihara, S., Murai, K. and Mueller, N. E. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int. J. Cancer, 56, 337-340 (1994).
11. Kozuru, M., Uike, N., Muta, K., Goto, T., Suehiro, Y. and Nagano, M. High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers. Cancer, 78, 1119-1124 (1996).
12. Iwata, K., Ito, S., Saito, H., Ito, M., Nagatomo, M., Yamasaki, T., Yoshida, S., Suto, H. and Tajima, K. Mortality among inhabitants of an HTLV-I endemic area in Japan. Jpn. J. Cancer Res., 85, 231-237 (1994).
13. Ishihara, S., Okayama, A., Stuver, S., Horinouchi, H., Shioiri, S., Murai, K., Kubota, T., Yamashita, R., Tachibana, N., Tsubouchi, H. and Mueller, N. Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J. Acquir. Immune Defic. Syndr., 7, 199-203 (1994).
14. Morand-Joubert, L., Mariotti, M., Reed, D., Petit, J.-C. and Lefrere, J.-J. Correlation between viral load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individuals. Int. J. Cancer, 60, 156-159 (1995).
15. Matsuo, T., Nakashima, E., Carter, R. L., Neriishi, K., Mabuchi, K., Akiyama, M., Shimaoka, K., Kinoshita, K., Tomonaga, M. and Ichimaru, M. Anti-human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. J. Radiat. Res., 36, 8-16 (1995).
16. Atomic Bomb Casualty Commission. Research plan for joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki. Hiroshima and Nagasaki, Japan: ABCC Technical Report 11-62 (1962).
17. IARC, WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 67, "Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses" (1996). IARC, Lyon, France.
18. Maeda, Y., Imai, J., Kiyokawa, H., Kanamura, M. and Hino, S. Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results. Jpn. J. Cancer Res., 80, 915-919 (1989).
19. Okochi, K., Sato, H. and Hinuma, Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang., 46, 245-253 (1984).
20. Kinoshita, T., Imamura, J., Nagai, H., Ito, M., Ito, S., Ikeda, S., Nagatomo, M., Tajima, K. and Shimotohno, K. Absence of HTLV-I infection among seronegative subjects in an endemic area of Japan. Int. J. Cancer, 54, 16-19 (1993).
21. Pierce, D. A., Shimizu, Y., Preston, D. L., Vaeth, M. and Mabuchi, K. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radiat. Res., 146, 1-27 (1996).
22. Collett, D. "Modelling Survival Data in Medical Research" (1994). Chapman and Hall, London, UK.
23. SAS Institute, Inc. SAS/STAT software: Changes and enhancements through Release 6.12. SAS Institute, Inc., Cary, NC (1997).
24. Maeda, Y., Furukawa, M., Takehara, Y., Yoshimura, K., Miyamoto, K., Matsuura, T., Morishima, Y., Tajima, K., Okochi, K. and Hinuma, Y. Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int. J. Cancer, 33, 717-720 (1984).
25. Tajima, K., Kamura, S., Ito, S., Ito, M., Nagatomo, M., Kinoshita, K. and Ikeda, S. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based cooperative study in Tsushima, Japan. Int. J. Cancer, 40, 741-746 (1987).
26. Tendler, C. L., Greenberg, S. J., Blattner, W. A., Manns, A., Murphy, E., Fleisher, T., Hanchard, B., Morgan, O., Burton, J. D., Nelson, D. L. and Waldman, T. A. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA, 87, 5218-5222 (1990).
27. Wilson, D. E., Birchfield, G. R., Hejazi, J. S., Ward, J. H. and Samlowski, W. E. Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteins. J. Clin. Oncol., 7, 1573-1577 (1989).
28. Ho, G. Y. F., Nelson, K., Nomura, A. M. Y., Polk, B. F. and Blattner, W. A. Markers of health status in an HTLV-I positive cohort. Am. J. Epidemiol., 136, 1349-1357 (1992).
29. Murphy, E. L., Wilks, R., Morgan, O. S., Hanchard, B., Cranston, B., Figueroa, J. P., Gibbs, W. N., Murphy, J. and Blattner, W. A. Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. Int. J. Epidemiol., 25, 1090-1097 (1996).
30. IARC, WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 59, "Hepatitis Virus" (1994). IARC, Lyon, France.
31. Kamihira, S., Yamada, Y., Sohda, H., Atogami, S., Tomonaga, M., Egawa, S., Fujii, M. and Chifu, K. Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma. Cancer Detect. Prev., 18, 329-334 (1994).
32. Okayama, A., Maruyama, T., Tachibana, N., Hayashi, K., Kitamura, T., Mueller, N. and Tsubouchi, H. Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus. Jpn. J. Cancer Res., 86, 1-4 (1995).
33. Kato, N., Nakazawa, T., Mizutani, T. and Shimotohno, K. Susceptibility of human T-lymphotropic virus type-I infected cell line MT-2 to hepatitis C virus infection. Biochem. Biophys. Res. Commun., 206, 863-869 (1995).
34. Stuver, S. O., Tachibana, N., Okayama, A. and Mueller, N. E. Evaluation of morbidity among human T lymphotropic virus type I carriers in Miyazaki, Japan. J. Infect. Dis., 173, 584-591 (1996).
35. Rothman, K. J. "Modern Epidemiology" (1986). Little, Brown and Company, Boston, MA/Toronto, Ontario.
36. Ron, E., Carter, R., Jablon, S. and Mabuchi, K. Agreement between death certificate and autopsy diagnoses among atomic bomb survivors. Epidemiology, 5, 48-56 (1994).